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Failure to thrive - an overlooked
manifestation of KMT2B-related dystonia:
a case presentation
Andrew Ng1,2, Serena Galosi3, Lisa Salz4, Terence Wong4, Caitlin Schwager5, Shivarajan Amudhavalli5,
Rose Gelineau-Morel5, Shimul Chowdhury4, on behalf of Rady Children’s Institute for Genomic Medicine
Investigators and Jennifer Friedman1,2,4*

Abstract
Background: KMT2B-related dystonia is a recently described form of childhood onset dystonia that may improve
with deep brain stimulation. Prior reports have focused on neurologic features including prominent bulbar
involvement without detailing general health consequences that may result from orolingual dysfunction. We
describe a family with novel KMT2B mutation with several members with failure to thrive to highlight this nonneurologic, but consequential impact of mutation in this gene.
Case presentation: We present a case of a 15-year old female who was admitted and evaluated for failure to
thrive. On exam, she had severe speech dysfluency, limited ability to protrude the tongue, and generalized dystonia
involving the oromandibular region, right upper and left lower extremity with left foot inversion contracture. The
proband and her parents underwent whole genome sequencing. A previously undescribed variant, c.4960 T > C
(p.Cys1654Arg), was identified in the KMT2B gene in the proband and mother, and this variant was subsequently
confirmed in two maternal cousins, one with failure to thrive. Literature review identified frequent reports of
prominent bulbar involvement but failure to thrive is rarely mentioned.
Conclusion: Failure to thrive is a common pediatric clinical condition that has consequences for growth and
development. In the presence of an abnormal neurologic exam, a search for a specific underlying genetic etiology
should be pursued. With this case series, we highlight an unusual potentially treatable cause of failure to thrive,
reinforce the importance of precise molecular diagnosis for patients with failure to thrive and an abnormal
neurologic exam, and underscore the importance of cascade screening of family members.
Keywords: KMT2B, Dystonia, Failure to thrive, Whole genome sequencing

Background
Failure to thrive (FTT), a common clinical condition
warrants hospitalization to ensure adequate nutrition
and thorough investigation of etiology. FTT is defined as
weight less than 0.4-5th percentile, weight less than 80%
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normal weight for age, or weight decline across more
than 2 major percentiles [1]. The causes include poor
nutrition, inadequate absorption, and increased energy
expenditure. Careful attention to history and comprehensive physical exam can yield clues to etiology.
Dystonia is a movement disorder characterized by involuntary hyperkinetic movements involving sustained
or intermittent contractions of agonist and antagonist
muscles that frequently lead to abnormal posturing or
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movements [2]. Dystonia is classified based on clinical
characteristics (age of onset, regional distribution, temporal pattern, coexistence of other movement disorders,
and other neurological manifestations) and etiology
(genetic, acquired, or idiopathic) [3]. Orolingual dystonia
can cause eating dysfunction leading to weight loss [4].
Lysine Methyltransferase-2B (KMT2B) dystonia is a
recently described autosomal dominant disorder [5, 6].
The KMT2B gene encodes a lysine methyltransferase
involved in H3K4 methylation, an epigenetic modifier
active in development [7]. This condition is characterized by childhood lower-limb onset dystonia that progressively generalizes with prominent cranial, cervical,
and laryngeal involvement [5, 6]. Though dysphagia has
been described, reports have focused on neurologic
rather than gastrointestinal symptomatology and presentation. We report the first case series where failure to
thrive was the presenting feature prompting diagnosis.
Our report identifies a novel KMT2B pathogenic variant,
c.4960 T > C (p.Cys1654Arg), and expands both the
spectrum of phenotypic presentation for KMT2B mutation and genetic causes for FTT.

Case presentation
A 15-year-old girl (III-1) was admitted to the hospital
for FTT: 36 kg(0.18%ile), 151 cm (4%ile). She had not
seen a physician for 2 years due to socioeconomic issues.
History revealed mild cognitive impairment, gait abnormality (left foot inversion) onset age 3, speech dysfluency
onset age 9, and slowness with eating onset age 13 with
dysphagia to solids and liquids onset age 14. Previous
evaluation for gait abnormality resulted in unsuccessful
trials of muscle relaxants and orthotics. Family history
was initially negative for neurologic conditions. On
exam, there was severe speech dysfluency, limited ability
to protrude the tongue, and generalized dystonia involving the oromandibular region, the right upper and the
left lower extremity with left foot inversion contracture
(Additional files 1, 2, 3).
Initially, neglect was considered a possible etiology
given the delay in seeking medical evaluation. However,
abnormal neurologic exam prompted further testing.
Labs were normal except for mild thrombocytopenia
likely due to malnutrition (Table 1). Brain magnetic
resonance imaging (MRI) showed bilateral hypointensity
in globi pallidi on susceptibility-weighted imaging
supporting an organic etiology (Fig. 1). Radiofilm revealed left foot 5th metatarsal fracture. Muscle biopsy
showed myopathic fiber size variation and mild vasculopathic changes. Video-swallow fluoroscopy showed
dysphagia to liquids and solids. Gastrostomy tube was
placed with significant weight gain but persistence of
weight below the second percentile despite appropriate
caloric intake. Levodopa/carbidopa and trihexyphenidyl
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Table 1 Laboratory Values during hospital admission
LABORATORY TEST

VALUE

REFERENCE RANGE

Hemoglobin (g/dL)

14.5

12.5–15

Hematocrit (% of g/dL)

42.2

35–45

Platelets (K/uL)

135

140–440

Sodium (mmol/L)

141

133–143

Potassium (mmol/L)

4.1

3.4–4.7

Chloride (mmol/L)

105

98–106

BUN (mg/dL)

9

8–21

Creatinine (mg/dL)

0.65

0.6–1.2

Calcium (mg/dL)

9.5

8.5–10.4

AST (U/L)

26

15–30

ALT (U/L)

20

5–30

Alkaline phosphatase (U/L)

99

70–280

Glucose (mg/dL)

93

70–106

Albumin (g/dL)

4.7

3.5–5.1

Vitamin D 25 OH (ng/mL)

17

> 30

TSH (uIU/mL)

0.37

0.35–5

Free T4 (ng/dL)

0.75

0.71–1.85

CK (U/L)

44

20–128

Folate (ng/mL)

11.7

>8

Vitamin B12 (pg/mL)

480

260–935

Copper (mcg/dL)

87

75–187

Ceruloplasmin (mg/dL)

21

21–46

AST aspartate transaminase, ALT alanine aminotransferase; Vitamin D 25 OH
calcifediol, TSH thyroid stimulating hormone, CK creatinine kinase

Fig. 1 Proband (III-1) MRI brain susceptibility weighted imaging
demonstrates moderate symmetric hypointensity in the bilateral
globi pallidi
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were not beneficial. Trio whole genome sequencing
(WGS) revealed a novel likely pathogenic heterozygous
c.4960 T > C (p.Cys1654Arg) variant in the proband and
mother in the KMT2B gene (Transcript ID: NM_
014727.2). This variant is not present in the gnomAD
database. The c.4960 T > C (p.Cys1654Arg) variant was
predicted by multiple in silico tools to have a deleterious
effect on protein function. No other diagnostic variants
were identified.
After identification of the KMT2B variant in the
proband and mother, additional history was obtained. A
three-generation pedigree was constructed (Fig. 2).
Cascade testing of maternal cousins (III-6 and III-7) revealed that they carried the same KMT2B c.4960 T > C
(p.Cys1654Arg) variant. The father (II-4) of maternal
cousins (III-6 and III-7) is an obligate carrier.
Mother, age 34(II-2), relayed history of painful right
arm posturing, worsening handwriting, intermittent
numbness, and gait disturbance onset age 29. She denied
speech changes or dysphagia. She recalled history of
encephalitis at age three. She was in special education
classes and was unable to complete high school. She had
anxiety onset age 19. Examination revealed normal
speech, right > left hand dystonia, right foot eversion
while ambulating, 4/5 weakness in finger extensors and
finger intrinsic muscles on the right, and 2 beats of clonus in the right ankle (Additional files 4, 5, 6). MRI
brain showed T2 hyperintensity without enhancement in
the deep and subcortical white matter of the left frontal
lobe suggesting remote infarct in the left middle cerebral
territory (Fig. 3).
Maternal male cousin, age 4(III-7), had delayed milestones, attention deficit hyperactivity disorder, anxiety,
and behavioral concerns. There was history of frequent
choking; however, video-fluroscopy was normal. Height
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Fig. 3 Mother (II-2) MRI brain showing T2 hyperintensity without
enhancement in the deep and subcortical white matter of the left
frontal lobe suggesting remote infarct in the left middle cerebral territory

was consistently less than the 10th percentile and weight
less than the 3rd percentile. Examination revealed hypernasal speech and preferential toe walking, although he
was able to walk heel toe when prompted.
Maternal female cousin, age 6(III-6), initially presented
for evaluation of hypernasal speech. A submucous cleft
palate was identified and she underwent a Furlow
palatoplasty without improvement. She had difficulties
swallowing as an infant, requiring feed thickener.

Fig. 2 Family Pedigree; Core features of KMT2B related dystonia are highlighted. + wild type; − KMT2B c.4960 T > C (p.Cys1654Arg) variant carrier;
* full term stillbirth. Individuals II-2; III-1, III-2; III-6; III-7 were directly examined. Features reported in other individuals are by report of relatives
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Dysphagia resolved over time. Growth was consistently
below the 10th percentile for height and weight. Early
toe walking improved with therapy. She has learning
delays and receives therapies and support in school.
Vision abnormalities include left-sided strabismic amblyopia, hyperopia, accommodative esotropia, and astigmatism. Neurological evaluation revealed hypernasal, but
fluent speech, normal resting tone with normal deep
tendon reflexes, and gait with external rotation of the
left leg with weight distribution on the lateral aspect of
the foot, suggesting mild dystonia.
Signs and symptoms in maternal grandfather and maternal uncles are reported by other relatives; none have
been examined by a neurologist. Maternal grandfather I1 had mild short stature and was aesthenic. Maternal
uncle, age 41(II-3), recently lost use of his left arm; he
has not had testing for the familial variant. Maternal
uncle, age 40(II-4), an obligate carrier of the variant, is
intellectually impaired and has short stature. He reported tingling and numbness in the neck that progressed to painful paresthesias in all four limbs onset
age 20.

Methods
Sequencing

WGS was performed as previously described [8, 9]. Variants were prioritized by allele frequency, conservation,
and predicted effect on protein function and confirmed
by Sanger sequencing. Phenotypic terms included the
following: dysarthria, gait disturbance, failure to thrive,
and dysphagia. Given MRI findings, the sequence was
re-queried to specifically exclude other variants in genes
associated with brain iron accumulation. Subsequent
family studies were performed by targeted Sanger
sequencing.
Literature review

We reviewed 80 cases obtained by PubMed Search using
term KMT2B as well as cases in the reference list for
these manuscripts or otherwise known to the author,
that were not identified by PubMed search. (Additional
Table).

Discussion and conclusions
Our report describes the phenotype in a family with a
previously undescribed KMT2B variant and highlights
failure to thrive, an overlooked manifestation. Thus far,
80 additional patients have been described (Additional
Table) [5, 6, 10–28]. A recent report identified KMT2B
mutations in 21.5% of patients with previously undiagnosed childhood-onset dystonia suggesting KMT2B
mutations may be a relatively common cause of dystonia
in children [26]. The natural course of KMT2B dystonia
involves focal onset lower limb dystonia with
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progression to generalization. Of reported cases, 23
noted dysphagia, 6 required gastrostomy tube but failure
to thrive was rarely mentioned (Additional Table) [5, 6,
10–28]. In our series, the proband and two cousins had
dysphagia. Poor weight gain despite normal swallowing
study in one cousin and refractory weight gain after gastrostomy tube placement in the proband, suggest factors
other than mechanical impairments to swallowing may
underlie FTT in this condition.
Progressive dystonia with prominent oromandibular
involvement, mild cognitive dysfunction and imaging
findings in the proband are consistent with features
previously described in KMT2B mutation carriers [6].
Other previously described neurologic features noted in
the proband include dysfluency, bulbar dysfunction, dysphagia, intellectual disability, and developmental delay
[5, 6]., Additional reported features not present include
eye movement abnormalities, skin changes, psychiatric
co-morbidities (anxiety, depression, attention deficit
hyperactivity disorder, obsessive-compulsive disorder),
myoclonus, seizures, spasticity, sensorineural hearing
loss, microcephaly, and parkinsonism [5, 6, 10–28].
Interestingly, the proband’s mother did not manifest
poor weight gain and reported no motor symptoms until
age 29. Similarly, maternal uncles report only adultonset neurologic symptoms. Reduced penetrance,
variable expressivity, and adult onset up to 43 years of
age have been reported [14, 26]. As neither maternal
grandfather, nor either maternal uncle was examined, we
cannot confirm whether dystonia is present. Similarly, it
is unclear if mother’s signs and symptoms are due to
genetic dystonia, unrecognized cerebrovascular accident,
or a combination of both given imaging evidence for remote infarct. Vascular insults have not been reported in
KMT2B mutation carriers though most reported cases
are children without long-term follow-up. Further study
will be necessary to determine whether KMT2B mutation is a risk factor for stroke.
Since molecular diagnosis, the proband has trialed
levodopa/carbidopa and trihexyphenidyl without benefit.
Deep brain stimulation of globus pallidus (DBS) is reported to improve dystonia in select patients, suggesting
another possible avenue for efficacious treatment for
affected members of this family [5, 6, 26].
Our case series underscores the importance of careful
history and thorough examination when determining etiologies for failure to thrive. In the presence of an
abnormal neurologic exam or history of developmental
delays, clinicians should strongly consider genetic testing. Unbiased genetic testing in this setting, including
whole exome and genome sequencing, has enabled
identification of rare disorders, especially those presenting with non-typical phenotypes. This case series highlights the non-neurologic aspects of KMT2B mutation
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and demonstrates the advantages of molecular genetic
testing for defining the precise and potentially treatable
etiologies of FTT. It also reinforces the importance of
cascade screening of family members to bring clarity of
unrecognized diagnoses more broadly beyond the
presenting family member.

Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12883-020-01798-x.
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Additional file 1. Patient (III-1) demonstrates orolingual dysphonia and
dystonia. In the last segment, she is asked to protrude her tongue but
cannot.
Additional file 2. Patient (III-1) demonstrates upper extremity dystonia
of right arm and lower extremity of left leg while sitting.
Additional file 3. Patient (III-1) demonstrates left lower limb dystonia
while ambulating.
Additional file 4. Patient’s mother (II-2) has normal speech without
dysarthria.
Additional file 5. Patient’s mother (II-2) displays right > > left hand
dystonia.
Additional file 6. Patient’s mother (II-2) displays mild bilateral arm
dystonia and right foot eversion while ambulating.
Additional file 7: Phenotype and Genotype of Previously Reported
KMT2B Mutation Carriers and Patients Described in This Report. F-Female;
M-Male.
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